These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19649706)

  • 1. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
    Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
    Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
    Zhu Y; Stevens RG; Leaderer D; Hoffman A; Holford T; Zhang Y; Brown HN; Zheng T
    Breast Cancer Res Treat; 2008 Feb; 107(3):421-5. PubMed ID: 17453337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.
    Yi CH; Zheng T; Leaderer D; Hoffman A; Zhu Y
    Cancer Lett; 2009 Nov; 284(2):149-56. PubMed ID: 19457610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.
    Hoffman AE; Zheng T; Ba Y; Zhu Y
    Mol Cancer Res; 2008 Sep; 6(9):1461-8. PubMed ID: 18819933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association of the NPAS2 gene Ala394Thr polymorphism (rs2305160:G>A) with risk of chronic lymphocytic leukemia.
    Rana S; Shahid A; Ullah H; Mahmood S
    Asian Pac J Cancer Prev; 2014; 15(17):7169-74. PubMed ID: 25227809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
    Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
    Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
    Zhu Y; Leaderer D; Guss C; Brown HN; Zhang Y; Boyle P; Stevens RG; Hoffman A; Qin Q; Han X; Zheng T
    Int J Cancer; 2007 Jan; 120(2):432-5. PubMed ID: 17096334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
    Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
    Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian genes and breast cancer susceptibility in rotating shift workers.
    Monsees GM; Kraft P; Hankinson SE; Hunter DJ; Schernhammer ES
    Int J Cancer; 2012 Dec; 131(11):2547-52. PubMed ID: 22473669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of NPAS2 in circadian rhythm and disease.
    Peng LU; Bai G; Pang Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Oct; 53(10):1257-1265. PubMed ID: 34415290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
    Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
    Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in
    He Y; Wang G; Wang Q; Zhao Z; Gan L; Yang S; Wang Y; Guo S; An J; Zhang J; Zhang Z; Zhou F
    Future Oncol; 2021 Mar; 17(7):795-805. PubMed ID: 33541123
    [No Abstract]   [Full Text] [Related]  

  • 13. Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer.
    Xue X; Liu F; Han Y; Li P; Yuan B; Wang X; Chen Y; Kuang Y; Zhi Q; Zhao H
    Biochem Biophys Res Commun; 2014 Jul; 450(2):1058-62. PubMed ID: 24978311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells.
    Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
    Cancer Lett; 2020 Jan; 469():498-509. PubMed ID: 31765736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of circadian gene NPAS2 in colorectal cancer and its prognostic significance].
    Yang SF; Xu M; Yang HY; Li PQ; Chi XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):714-8. PubMed ID: 27222192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
    Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
    World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hylan G-F 20 attenuates posttraumatic osteoarthritis progression: Association with upregulated expression of the circardian gene NPAS2.
    Liu CC; Su LJ; Tsai WY; Sun HL; Lee HC; Wong CS
    Life Sci; 2015 Nov; 141():20-4. PubMed ID: 26388558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CLOCK, ARNTL, and NPAS2 gene polymorphisms and seasonal variations in mood and behavior.
    Kim HI; Lee HJ; Cho CH; Kang SG; Yoon HK; Park YM; Lee SH; Moon JH; Song HM; Lee E; Kim L
    Chronobiol Int; 2015; 32(6):785-91. PubMed ID: 26134245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
    Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
    BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer.
    Chen Y; Wang D; Song Y; Zhang X; Jiao Z; Dong J; Lü L; Zou Z; Du W; Qu F
    Cancer Med; 2019 Apr; 8(4):1919-1929. PubMed ID: 30843665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.